Recent advances in research on multistage tumorigenesis

British Journal of Cancer

Volumn 83, Issue 1, 2000, Pages 1-5

  Compagni, A ^a   Christofori, G ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

Cancer; Oncogenes; Transgenic mice; Tumour suppressor genes

Indexed keywords

ANGIOGENESIS; APOPTOSIS; CANCER RESEARCH; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; METASTASIS; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

EID: 0034129118     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1309     Document Type: Review

References (71)

1. Ali IU, Schriml LM and Dean M (1999) Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 91: 1922-1932
2. Baserga R (1999) The IGF-1 receptor in cancer research. Exp Cell Res 253: 1-6
3. Becker D, Meier CB and Herlyn M (1989) Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. Embo J 8: 3685-3691
4. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S and Wright WE (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352
5. Bouck N, Stellmach V and Hsu SC (1996) How tumors become angiogenic. Adv Cancer Res 69: 135-174
6. Brooks PC, Silletti S, von Schalscha TL, Friedlander M and Cheresh DA (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92: 391-400
7. Bullions LC and Levine AJ (1998) The role of beta-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol 10: 81-87
8. Cahill DP, Lengauer C, Yu J, Riggins GJ, Wilson JK, Markowitz SD, Kinzler KW and Vogelstein B (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392: 300-303
9. Chin L, Pomerantz J and DePinho RA (1998) The INK4a/ARF tumor suppressor: one gene - two products - two pathways. Trends Biochem Sci 23: 291-296
10. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW and DePinho RA (1999a). p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97: 527-538
11. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW, 2nd, Cordon-Cardo C, Yancopoulos GD and DePinho RA (1999b). Essential role for oncogenic Ras in tumour maintenance. Nature 400: 468-472
12. Christofori G and Semb H (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24: 73-76
13. Christofori G, Naik P and Hanahan D (1994) A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369: 414-418
14. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH and Hanahan D (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13: 1382-1397
15. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P and Matrisian LM (1999) The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18: 2883-2891
16. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP and Bouck N (1998) Thrombospondin-1 is a major activator of TGF-betal in vivo. Cell 93: 1159-1170
17. Dameron KM, Volpert OV, Tainsky MA and Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584
18. Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A and Lee EY (1999) DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 18: 7883-7899
19. Downward J. (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10, 262-267
20. Duval A, lacopetta B, Ranzani GN, Lothe RA, Thomas G and Hamelin R. (1999) Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability. Oncogene 18: 6806-6809
21. Eastman Q and Grosschedl R (1999) Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11: 233-240
22. Ewald D, Li M, Efrat S, Auer G, Wall RJ, Furth PA and Hennighausen L (1996) Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273: 1384-1386
23. Fedi P, Tronick SR and Aaronson SA (1997) Growth factors. In: Cancer Medicine, Holland JF, Bast RC, Morton DL, Frei E, Kufe DW and Weichselbaum RR (eds) pp 41-64. Williams and Wilkins: Baltimore, MD
24. Felsher DW and Bishop JM (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4: 199-207
25. Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527-543
26. Ferrara N and Alitalo K (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5: 1359-1364
27. Fingleton BM, Heppner Goss KJ, Crawford HC and Matrisian LM (1999) Matrilysin in early stage intestinal tumorigenesis. Apmis 107: 102-110
28. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
29. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31
30. Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, Greider CW and DePinho RA (1999) Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97: 515-525
31. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A and Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392: 402-405
32. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW and Weinberg RA (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464-468
33. Hanahan D and Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364
34. Harrington EA, Bennett MR, Fanidi A and Evan GI (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. Embo J 13: 3286-3295
35. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512
36. Herman JG (1999) Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol 9: 359-367
37. Holt SE and Shay JW (1999) Role of telomerase in cellular proliferation and cancer. J Cell Physiol 180: 10-18
38. Hueber AO, Zornig M, Lyon D, Suda T, Nagata S and Evan GI (1997) Requirement for the CD95 receptor-ligand pathway in c-Myc induced apoptosis. Science 278: 1305-1309
39. Huebner K, Garrison PN, Barnes LD and Croce CM (1998) The role of the FHIT/FRA3B locus in cancer. Annu Rev Genet 32: 7-31
40. Jaattela M (1999) Escaping cell death: survival proteins in cancer. Exp Cell Res 248: 30-43
41. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL and Bouck N (2000) Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-I. Nat Med 6: 41-418
42. Karlseder J, Broccoli D, Dai Y, Hardy S and de Lange T (1999) p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283: 1321-1325
43. Kinzler KW and Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170
44. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC -/-colon carcinoma. Science 275: 1784-1787
45. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA and Jaenisch R (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81: 197-205
46. Lengauer C, Kinzler KW and Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396: 643-649
47. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M and Lowe SW (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12: 3008-3019
48. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE and Shay JW (1999) Absence or cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21: 115-118
49. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW (1997) Activation of beta-catenin-Tef signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790
50. Pelengaris S, Littlewood T, Khan M, Elia G and Evan G (1999) Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 3: 565-577
51. Peltomaki P and de la Chapelle A (1997) Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv Cancer Res 71: 93-119
52. Perl AK, Wilgenbus P, Dabl U, Semb H and Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193
53. Polakis P (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1332: F127-147
54. Rabbani SA (1998) Metalloproteases and urokinase in angiogenesis and tumor progression. In Vivo 12: 135-142
55. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14: 34-44
56. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E and Polakis P (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792
57. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C and DePinho RA (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96: 701-712
58. Schwartz S Jr, Yamamoto H, Navarro M, Maestro M, Reventos J and Perucho M (1999) Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 59: 2995-3002
59. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578
60. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p161INK4a. Cell 88: 593-602
61. Sherr CJ (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev 12: 2984-2991
62. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527
63. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39
64. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ and Werb Z (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98: 137-146
65. Tetsu O and McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426
66. Toyota M and Issa JP (1999) CpG island methylator phenotypes in aging and cancer. Semin Cancer Biol 9: 349-357
67. Wilson CL, Heppner KJ, Labosky PA, Hogan BL and Matrisian LM (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94: 1402-1407
68. Yarden Y and Ullrich A (1988) Growth factor receptor tyrosine kinases. Annu Rev Biochem 57: 443-478
69. Zhang X, Mar V, Zhou W, Harrington L and Robinson MO (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 13: 2388-2399
70. Zhu J, Woods D, McMahon M and Bishop JM (1998) Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 12: 2997-3007
71. Zindy F, Fischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 12: 2424-2433